Aptuit Deploys Clinicopia(R) Labeling Solution at Global Clinical Packaging and Logistic Facilities.

Launch of Best-of-Breed Clinical Labeling Technology Marks Successful Milestone Toward Global Deployment of Entire Clinicopia Suite

AGOURA HILLS, Calif. -- Aptuit, Inc. announced today that it has successfully deployed the integrated labeling solution from the industry standard Clinicopia([R]) Suite globally within its Clinical Packaging and Logistics (CPL) facilities in Deeside, Wales; Bathgate, Scotland; Allendale, NJ; Mount Laurel, NJ; and Kansas City, MO. Clinicopia is the world's first purpose-built, industry-specific Clinical Trial Supply Management Suite developed from the ground up, and it is the most comprehensive end-to-end solution available for the clinical supply industry today. By implementing the labeling component of Clinicopia within its Clinical Packaging and Logistics facilities, Aptuit has achieved the first milestone in a multi-phase roll-out of the entire Clinicopia Suite across all of its facilities worldwide. Eventually, the Clinicopia Suite will act as the "information spine" of Aptuit, offering clients increased transparency and real-time data access for all of their projects.

Clinicopia Labeling is a clinical label creation and management system that allows the integration of random data, as well as thermal and laser printing. It utilizes features such as a Java-based graphics editor, a graphical user interface, and a global electronic web-approval routing system. Clinicopia Labeling provides the complete functionality needed to develop artwork for labels used on all packages associated with a clinical study and is currently being used by many top-tier pharmaceutical companies around the globe.

"By implementing this technology within our facilities, we have taken the first step in the global roll-out of a comprehensive drug management system, ultimately creating the industry's first seamless IT system that enables complete client-accessible project management and test data," said Scott Houlton, President, Clinical Operations of Aptuit.

With Clinicopia Labeling in place, Aptuit plans initially to utilize this revolutionary internet-based technology internally to increase the speed and efficiency of clinical packaging and logistics for clients. Ultimately, Aptuit will make the system available to clients to enable them to directly access the application's functionality to monitor their projects from anywhere, in real-time. Clients will be able to utilize features, such as an electronic routing system and web approval, a pre-approved phrase library, and two-way genealogy, without having to license the product or navigate through an extensive validation and implementation process.

"As one of the first steps in our mission to engineer a better drug development process, we are streamlining our internal infrastructure and practices. The completion of this initial phase will allow us to provide our clients with a world-class turnkey solution for their labeling outsourcing needs," said Michael A. Griffith, CEO of Aptuit. "Clinicopia is an industrially-robust solution and, once fully installed, will play an important role in the realization of the industry's first end-to-end IT solution for the entire drug development continuum."

Aptuit has made a significant investment toward institutionalizing the Clinicopia Solution offering by qualifying the software so that users can implement it without the need for operation qualification (OQ) tests. Clients can use the software in their IT environment with just a performance qualification (PQ), significantly reducing the cost and effort to either deploy or upgrade to a newer version. The 4.1 Straight-to-PQ version is expected to be available to clients in the first quarter of 2007.

About Aptuit:

Aptuit, Inc. is a global company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators. The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment. Aptuit provides a comprehensive suite of product development services and competencies to biotechnology companies and large, fully integrated pharmaceutical companies worldwide. Currently, the company has more than 2,000 employees, 12 global facilities, and resources to reach 70 countries. Aptuit's mission is to engineer a better drug development process, and is partnered with Welsh, Carson, Anderson & Stowe, one of the world's largest private equity investors. For more information about Aptuit, please visit http://www.aptuit.com.

About Aptuit Informatics:

Aptuit Informatics develops, implements, and maintains enterprise-class, mission-critical information systems for the drug development markets within the pharmaceutical and biotechnology industries. Aptuit Informatics has developed numerous solutions in the clinical trials space to help customers manage and achieve excellence in their extended clinical supply chains. Ultimately, the company will develop the industry's first seamless IT system that enables end-to-end customer-accessible project management and test data across the entire drug development continuum. Its clients include: AstraZeneca, Abbott Laboratories, Chiron, Organon, Procter & Gamble, and Pfizer.